Skip to main content
Caplight Logo









TargTex

TargTex

Private
Torres VedrasHealthcare & Life Scienceshttps://targtex.com/

Last Round

Seed

Feb 14, 2022

Total Funding Raised

$2.27M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

TargTex is a biotechnology company that develops innovative localized therapies for hard-to-treat tumors, including a hydrogel-based delivery system for Glioblastoma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoveryglioblastoma treatmenthydrogel drug deliverylocalized therapyTRPV2drug-device combinationoncologyai drug discoveryin-silico drug designperioperative caremedical devicesbiotech startupprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TargTex Comparables

Compare TargTex with similar companies based on industry and business-model similarity.

TargTex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OncoLize
83%
Hemerion Therapeutics
80%
Double Bond Pharmaceutical International AB
80%

TargTex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 14, 2022
GrantDec 1, 2019
SeedJul 10, 2019

Key People

Founding team and executive leadership

Pedro M.S.D. Cal

Co-Founder and Chief Operating Officer

Founding Team

João Seixas

Co-founder & CEO

Founding Team

TargTex Investors

Notable investors and investment history

TargTex investors
InvestorRounds
Portugal VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors increased 46% MoM.

  • Jul 2, 2025

    Monthly visitors increased 33% MoM.

TargTex Filings

Explore SEC and related filing metadata, where available.

TargTex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TargTex's valuation, stock price, and market status.

Is TargTex a public or private company?

TargTex is a private company.

What is the current stock price of TargTex?

TargTex is a private company with no public stock price. No recent secondary market data is available.

How much is TargTex worth (valuation)?

Valuation information for TargTex is not publicly available.

Can I buy TargTex stock?

TargTex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TargTex's last funding round?

TargTex's most recent funding round was Seed on February 14, 2022.

Who are the main investors in TargTex?

Key investors in TargTex include Portugal Ventures.

Will TargTex IPO soon?

No public IPO plans have been announced for TargTex.

How can I track TargTex secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TargTex's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTorres Vedras
Employee Range5
Year Founded2019
Last FundingFeb 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?